<?xml version="1.0" encoding="UTF-8"?>
<p>The legislation in most countries also does not address the use of unproven and/or potentially harmful products with respect to the quantity and quality of the components listed on the product’s label. In a survey examining 50 herbal medicinal products with the word “ginseng” appearing on their labels, each product was tested for the presence and levels of the active component ginsenoside ((20
 <italic>S</italic>)-protopanaxadiol and (20
 <italic>S</italic>)-protopanaxatriol). It was discovered that six of the 50 products examined (12.0%) did not contain any active component whatsoever, while the remainder contained between 1.9% and 9.0% of the active component [
 <xref rid="B26-pharmaceuticals-13-00455" ref-type="bibr">26</xref>]. Standardization of herbal components is a complicated process, even more so when a number of herbal compounds are combined and sold as a formula, a common practice in traditional Chinese and other schools of medicine. Methods used to ensure batch-to-batch consistency of the herbal compound/s being investigated are mass spectrometry and high-performance liquid chromatography (HPLC). Spectrometry has been used to evaluate individual herbs [
 <xref rid="B27-pharmaceuticals-13-00455" ref-type="bibr">27</xref>,
 <xref rid="B28-pharmaceuticals-13-00455" ref-type="bibr">28</xref>], and HPLC has been used for herbal formulas containing a number of compounds, thereby providing reliable and reproducible findings regarding their safety and efficacy in the oncology setting (e.g., the herbal formulas PHY906 and LCS101 [
 <xref rid="B29-pharmaceuticals-13-00455" ref-type="bibr">29</xref>,
 <xref rid="B30-pharmaceuticals-13-00455" ref-type="bibr">30</xref>]).
</p>
